What is the function of Complex I in the electron transport chain?
Which of the following is a structural component of matrix vesicles?
In the tricarboxylic acid cycle, which compound is first formed?
Malonate is a competitive inhibitor of
Which of the following is not an antioxidant?
All of the following are associated with increased aging, except which of the following?
The inhibitor of the complex IV of the electron transport chain is
Which of the following biochemical reactions is associated with substrate-level phosphorylation?
What is the major fuel utilized by the brain after one week of fasting?
Which of the following is NOT a finding within 24 hours of starvation in a 19-year-old patient with Anorexia Nervosa?
Explanation: ***NADH - CoQ reductase*** - Complex I, also known as **NADH dehydrogenase**, transfers electrons from **NADH** to **Coenzyme Q (CoQ)**. - This process oxidizes NADH to NAD+ and pumps protons from the **mitochondrial matrix** to the **intermembrane space**, contributing to the proton gradient. - Complex I is the entry point for electrons from NADH into the electron transport chain and generates approximately **4 H+ ions** pumped per 2 electrons. *CoQ - cytochrome C reductase* - This describes the function of **Complex III**, not Complex I. - Complex III (cytochrome bc1 complex) transfers electrons from **reduced CoQ (ubiquinol)** to **cytochrome c**. - It also contributes to proton pumping via the Q-cycle mechanism. *Cytochrome-C oxidase* - This describes the function of **Complex IV**, not Complex I. - Complex IV transfers electrons from **cytochrome c** to **molecular oxygen (O2)**, forming water (H2O). - It is the terminal enzyme of the electron transport chain and pumps protons across the membrane. *None of the options* - This option is incorrect because Complex I clearly functions as **NADH - CoQ reductase**. - Each complex (I, II, III, and IV) has distinct enzymatic functions in the electron transport chain, and Complex I's role is well-established.
Explanation: ***Alkaline phosphatase*** - **Alkaline phosphatase** (ALP) is a **key membrane-bound enzyme** and structural component of matrix vesicles. - It plays a critical role in **modulating phosphate concentrations** by hydrolyzing pyrophosphate, thereby promoting mineralization. - ALP is considered the **most characteristic enzymatic marker** of matrix vesicles. *Calcium ATPase* - Calcium ATPase (PMCA) is indeed a **membrane protein present in matrix vesicles** and functions in calcium transport. - However, **alkaline phosphatase** is more widely recognized as the **primary structural and functional marker** of matrix vesicles in standard medical literature. - While both are membrane components, ALP is the classical answer for matrix vesicle identification. *Metallo proteinase* - **Metalloproteinases** are enzymes involved in **extracellular matrix remodeling** and degradation. - They are not structural components of matrix vesicles, although they may interact with the matrix during mineralization. *Calcium phosphate* - **Calcium phosphate** is the mineral that *forms within* and *is deposited by* matrix vesicles during biomineralization. - It is the **product** of matrix vesicle activity, not a structural component of the vesicle itself.
Explanation: ***Citrate*** - **Citrate** is the first compound formed in the TCA cycle when **acetyl-CoA** (a two-carbon molecule) combines with **oxaloacetate** (a four-carbon molecule) in a reaction catalyzed by **citrate synthase**. - This condensation reaction yields a six-carbon molecule, **citrate**, marking the beginning of the cyclical pathway. *Isocitrate* - **Isocitrate** is formed from **citrate** via an isomerization reaction catalyzed by **aconitase**. - This reaction involves the temporary formation of **cis-aconitate** as an intermediate before forming isocitrate. *Fumarate* - **Fumarate** is a compound formed later in the cycle, specifically from the oxidation of **succinate** by **succinate dehydrogenase**. - This step produces **FADH2** and is part of the final stages of regenerating oxaloacetate. *Succinate* - **Succinate** is formed after **succinyl-CoA** is converted to succinate by **succinyl-CoA synthetase**, a reaction that produces **GTP** (or ATP). - This is a key substrate-level phosphorylation step within the TCA cycle, occurring after the decarboxylation reactions.
Explanation: ***Succinate dehydrogenase (Complex II)*** - Malonate is a structural analog of **succinate**, the natural substrate of **succinate dehydrogenase**. - Its similar structure allows it to bind to the **active site** of the enzyme, competitively inhibiting its activity. *NADH dehydrogenase (Complex I)* - This complex is involved in the oxidation of **NADH**, not succinate, and thus malonate has no direct inhibitory effect. - Inhibitors of Complex I typically include substances like **rotenone** and **amytal**. *Cytochrome c oxidase (Complex IV)* - This enzyme catalyzes the reduction of oxygen to water and is inhibited by substances like **cyanide** and **carbon monoxide**. - Malonate's mechanism of action is unrelated to this final step of the electron transport chain. *Cytochrome bc1 complex (Complex III)* - This complex transfers electrons from ubiquinol to cytochrome c and is typically inhibited by agents like **antimycin A**. - Malonate does not structurally resemble the substrates or cofactors involved in Complex III activity.
Explanation: ***Micronutrients like Iron*** - Iron is a **pro-oxidant**, not an antioxidant, as it catalyzes the formation of **free radicals** through Fenton reactions [1]. - While essential for many biological processes, it can lead to increased **oxidative stress** when present in excess. *Transport proteins like transferrin, Ceruloplasmin* - These proteins act as **antioxidants** by transporting metal ions and facilitating their redox reactions, helping to prevent oxidative damage. - Transferrin binds iron tightly, reducing its availability for free radical formation, thus exhibiting **protective effects**. *Enzymes like glutathione peroxidase, superoxide dismutase* - These enzymes are crucial **antioxidants** that neutralize reactive oxygen species (ROS) and protect cells from oxidative damage [1]. - They help maintain redox balance and prevent cellular damage caused by excessive **oxidative stress**. *Vitamins like C and E* - Vitamins C and E are well-known **antioxidants** that help neutralize free radicals in the body and protect cellular integrity. - Vitamin C acts as a **water-soluble** antioxidant, while Vitamin E is a **lipid-soluble** antioxidant, both essential for preventing oxidative damage. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 59.
Explanation: ***Increased superoxide dismutase (SOD)*** - SOD is an important enzyme that provides **cellular protection** by catalyzing the conversion of superoxide radicals into less harmful molecules [1][2]. - Elevated levels of SOD contribute to oxidative stress defense, which is beneficial and not typically associated with **aging** [1][2]. *Accumulated mutations in somatic cells* - With aging, there is typically an **increase in mutations**, which can lead to cellular dysfunction and aging-related diseases. - These mutations result from accumulated DNA damage over time and contribute to the aging process rather than provide protection. *Increased cross-linkages in collagen* - Aging is associated with the development of **cross-linkages in collagen**, leading to **tissue stiffness** and reduced function. - This process negatively impacts cellular function and contributes to aging rather than offering any form of cellular protection. *Increased accumulation of free radicals* - Aging is characterized by an **increase in free radicals**, leading to oxidative damage to cells and tissues [1][2]. - This accumulation can accelerate the aging process and does not provide protective benefits to cells [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 100-101. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Cellular Responses to Stress and Toxic Insults: Adaptation, Injury, and Death, p. 59.
Explanation: ***Hydrogen sulfide*** - **Hydrogen sulfide (H2S)** is a classic inhibitor of **Complex IV (cytochrome c oxidase)** in the electron transport chain. - It binds to the **heme a3-CuB center** of cytochrome c oxidase, preventing the transfer of electrons to oxygen, thereby arresting **oxidative phosphorylation**. *Barbiturates* - **Barbiturates**, particularly **amobarbital**, are known inhibitors of **Complex I (NADH dehydrogenase)**. - They interfere with the transfer of electrons from NADH to ubiquinone at the flavin mononucleotide (FMN) binding site. *Antimycin A* - **Antimycin A** specifically inhibits **Complex III (cytochrome bc1 complex)** of the electron transport chain. - It binds to the **Qi site** of complex III, blocking the transfer of electrons from ubiquinol to cytochrome c1. *Dimercaprol* - **Dimercaprol** (also known as **BAL** or British Anti-Lewisite) is a chelating agent used to treat heavy metal poisoning. - It does not directly inhibit the electron transport chain components but acts by binding to **heavy metal ions**.
Explanation: ***Succinyl CoA to Succinate*** - This reaction, catalyzed by **succinyl CoA synthetase** (or succinate thiokinase) in the **Krebs cycle**, directly phosphorylates GDP to GTP (or ADP to ATP) using the high-energy thioester bond of succinyl CoA. - It is a classic example of **substrate-level phosphorylation** because ATP/GTP is generated directly from an energy-rich substrate without the involvement of an electron transport chain. *Fumarate to malate* - This step in the **Krebs cycle** is catalyzed by **fumarase** and involves the hydration of fumarate to malate, not a phosphorylation event. - It conserves no energy in the form of ATP or GTP directly and is part of the pathway that ultimately feeds electrons into the electron transport chain. *Succinate to fumarate* - This reaction is catalyzed by **succinate dehydrogenase**, a component of both the **Krebs cycle** and **Complex II of the electron transport chain**. - It results in the reduction of FAD to FADH2, which then contributes electrons to oxidative phosphorylation, but there is no direct ATP/GTP synthesis. *Acetoacetate to α-ketoglutarate* - This is an incorrect or unusual biochemical transformation; **acetoacetate** is a **ketone body**, and **α-ketoglutarate** is an intermediate in the **Krebs cycle**. - These molecules typically participate in different metabolic pathways, and their direct conversion is not a recognized reaction involving substrate-level phosphorylation.
Explanation: ***Ketone bodies*** - After prolonged fasting (typically more than 2-3 days), the brain significantly increases its utilization of **ketone bodies** (acetoacetate and β-hydroxybutyrate) as an alternative fuel source. - This adaptation helps to spare **glucose** for red blood cells and other cells that exclusively rely on it, as hepatic glucose production cannot keep up with demand during prolonged fasting. *Blood glucose* - While normally the primary fuel for the brain, **blood glucose levels** decline during prolonged fasting due to depleted glycogen stores and limited gluconeogenesis. - The brain reduces its reliance on glucose to conserve the body's diminishing glucose supply, shifting towards alternative fuels. *Fatty acids* - **Fatty acids** cannot directly cross the blood-brain barrier efficiently and therefore are not a primary fuel source for the brain. - However, fatty acids are oxidized in the liver to produce **ketone bodies**, which can cross the barrier and be utilized by the brain. *Glycogen* - The brain stores very small amounts of **glycogen**, primarily in astrocytes, which is quickly depleted within minutes to hours of fasting. - Therefore, brain glycogen is not a significant fuel source for the brain during prolonged fasting.
Explanation: ***Decrease in serum proteins*** - **Serum protein levels** generally decrease only after a prolonged period of starvation (weeks to months), as the body initially catabolizes proteins from less vital tissues. - In the **initial 24 hours of starvation**, the body primarily relies on glycogenolysis and lipolysis, with significant protein breakdown occurring later. *Increase in free fatty acids* - Within **24 hours of starvation**, the body switches from carbohydrate metabolism to fat utilization due to declining insulin and rising glucagon levels. - This leads to increased **lipolysis** in adipose tissue, releasing **free fatty acids** into circulation to be used as fuel. *Increase in ketone bodies* - As **free fatty acid** levels rise, the liver converts them into **ketone bodies** (beta-hydroxybutyrate and acetoacetate) which become an important energy source for tissues like the brain during starvation. - This process, known as **ketogenesis**, accelerates within the first 24 hours to 3 days of food deprivation. *Decrease in glycogen* - The body's primary immediate energy reserve, **glycogen** (stored in the liver and muscles), is rapidly depleted within the first **12-24 hours of starvation** through **glycogenolysis**. - Liver glycogen is particularly crucial for maintaining blood glucose levels during this initial phase.
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free